Precision Spine Appoints Two New Board Members

PARSIPPANY, N.J.--(BUSINESS WIRE)--Precision Spine, Inc. today announced that it has appointed Gilbert M. Aust, M.D. and Jeffrey P. Kelly to the company's Board of Directors.

"Our two new Board members bring a vast array of skills and insights from important sectors of our industry, adding their considerable knowledge to that of our other Board members, Stephen D. Cook, Ph.D. and Anthony J. Dimun," said Jim Pastena, CEO and Chairman of the Board of Precision Spine, Inc. "Gil brings to the table tremendous technological, operational and leadership expertise gained as a surgeon, device designer and entrepreneur.

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

While the biotech IPO market booms, it can look like going public is easy. But the right strategy, syndicate and aftermarket are still important.

Gene therapy pioneer Jim Wilson and the University of Pennsylvania are teaming up with Regeneron to help deliver its COVID antibody intransally.

Forty percent of PK deficiency patients on mitapivat had hemoglobalin responses, compared to 0% in the placebo group.